

Coca-Cola Europacific Partners vs Kimberly-Clark
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kleenex, Huggies, and Scott paper products to households around the world. Coca-Cola Europacific Partners vs Kimberly-Clark both generate predictable cash flows from consumer staples brands with deep shelf-space dominance, making them favorites for dividend investors. The analysis examines organic revenue growth, volume trends, cost pass-through ability, and which company delivers stronger earnings per share growth.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kl...
Why It's Moving

CCEP Stock Warning: Why Analysts See -3% Downside Risk
- Barclays cut its price target from $111 to $106 earlier this month, signaling tempered growth expectations despite maintaining an overweight rating.
- Recent trading shows price gains with sharply dropping volume, a classic warning sign that momentum could fade and risk heighten in the near term.
- Bearish technicals emerge as the 5-day SMA crosses below the 10-day SMA, with mid-term moving averages pointing to downward pressure against support levels around $94-98.

Kimberly-Clark Stock Faces Mixed Analyst Outlook as UBS Trims Price Target Amid Revenue Headwinds
- UBS Group cut its price target to $105 from $110 with a maintained neutral rating, joining multiple brokerages in trimming forecasts recently as revenue declined 0.6% year-over-year
- The company beat earnings estimates with Q1 EPS of $1.86 but posted a revenue miss, raising concerns about demand headwinds offset by operational efficiency
- Analyst consensus remains split with 3 buys, 11 holds, and 1 sell among recent ratings, though the stock's high debt-to-equity ratio of 3.97 is weighing on investor sentiment

CCEP Stock Warning: Why Analysts See -3% Downside Risk
- Barclays cut its price target from $111 to $106 earlier this month, signaling tempered growth expectations despite maintaining an overweight rating.
- Recent trading shows price gains with sharply dropping volume, a classic warning sign that momentum could fade and risk heighten in the near term.
- Bearish technicals emerge as the 5-day SMA crosses below the 10-day SMA, with mid-term moving averages pointing to downward pressure against support levels around $94-98.

Kimberly-Clark Stock Faces Mixed Analyst Outlook as UBS Trims Price Target Amid Revenue Headwinds
- UBS Group cut its price target to $105 from $110 with a maintained neutral rating, joining multiple brokerages in trimming forecasts recently as revenue declined 0.6% year-over-year
- The company beat earnings estimates with Q1 EPS of $1.86 but posted a revenue miss, raising concerns about demand headwinds offset by operational efficiency
- Analyst consensus remains split with 3 buys, 11 holds, and 1 sell among recent ratings, though the stock's high debt-to-equity ratio of 3.97 is weighing on investor sentiment
Investment Analysis
Pros
- Reported solid Q3 2025 revenue growth of 1.0%, driven by volume growth and higher revenue per unit case.
- Continues to increase market share ahead of competition within its territories.
- Receives mostly positive analyst sentiment, with an average price target indicating upside potential near 9-19%.
Considerations
- Modest volume growth at only 0.4% in Q3 suggests limited near-term expansion in core beverage sales.
- Analyst opinions are mixed, with some Hold and Sell ratings alongside Buy recommendations, reflecting some uncertainty.
- Short selling activity remains notable at 8.88%, indicating some investor bearishness or hedging.
Pros
- Kimberly-Clark's price-to-earnings ratio of 16.27 is below its 3-, 5-, and 10-year averages, potentially indicating value relative to its history.
- Market capitalization around $31 billion reflects its status as a leading global consumer goods company.
- Maintains steady financial metrics amid competitive pressure in personal care and household products.
Considerations
- Current PE ratio below historical averages may partly reflect slower growth or margin pressure concerns.
- Faces industry-wide challenges including inflationary cost pressures and evolving consumer preferences.
- Competitive dynamics could impact pricing power and margin sustainability in key product categories.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
Coca-Cola Europacific Partners (CCEP) is estimated to announce its next earnings between July 6 and July 15, 2026. This report will cover the second quarter of 2026 (Q2 2026), following the company's most recent release on February 17, 2026, for the prior period. The date remains projected based on historical patterns, as no official announcement has been made.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark (KMB) is scheduled to report its Q1 2026 earnings tomorrow, on April 28, 2026, before the market opens. This release will cover the first quarter of 2026, with a conference call at 8:00 AM ET. The prior quarter's results were announced on January 27, 2026, aligning with the company's typical late-January and late-April pattern for quarterly disclosures.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
Coca-Cola Europacific Partners (CCEP) is estimated to announce its next earnings between July 6 and July 15, 2026. This report will cover the second quarter of 2026 (Q2 2026), following the company's most recent release on February 17, 2026, for the prior period. The date remains projected based on historical patterns, as no official announcement has been made.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark (KMB) is scheduled to report its Q1 2026 earnings tomorrow, on April 28, 2026, before the market opens. This release will cover the first quarter of 2026, with a conference call at 8:00 AM ET. The prior quarter's results were announced on January 27, 2026, aligning with the company's typical late-January and late-April pattern for quarterly disclosures.
Buy CCEP or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


